Metraipolis › archive › dc_17bd8a2d941a

The UBE2/E2 ubiquitin-conjugating enzyme family at the interface of tumor biology and antitumor immunity: mechanisms, biomarkers, and therapeutic opportunities — Europe PMC PMID:42358995

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358995
DOI
10.3389/fimmu.2026.1847760
License (as archived)
solo-consultazione
Archived
2026-10-31T14:55:04.345Z
SHA-256 of the archived text
0dca1495735a873ef40d5a8f00a50e9220e11d7cda97730965c0725c5ecab1d7
Stable URL of this page
https://metraipolis.com/documento/dc_17bd8a2d941a

How to cite

The UBE2/E2 ubiquitin-conjugating enzyme family at the interface of tumor biology and antitumor immunity: mechanisms, biomarkers, and therapeutic opportunities — Europe PMC PMID:42358995 — Europe PMC (en), https://europepmc.org/article/MED/42358995 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17bd8a2d941a (Metraipolis archive dc_17bd8a2d941a, sha256 0dca1495735a873ef40d5a8f00a50e9220e11d7cda97730965c0725c5ecab1d7)
BibTeX
@misc{dc17bd8a2d941a,
  title = {The UBE2/E2 ubiquitin-conjugating enzyme family at the interface of tumor biology and antitumor immunity: mechanisms, biomarkers, and therapeutic opportunities — Europe PMC PMID:42358995},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358995},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17bd8a2d941a; sha256 0dca1495735a873ef40d5a8f00a50e9220e11d7cda97730965c0725c5ecab1d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358995. Agents can read the archived copy with the MCP tool read_document.